Introducing the pneumococcal conjugate vaccine in India's National Immunization Programme: an economic-epidemiological analysis using agent-based modelling

Research output: Contribution to conferenceAbstract

Abstract

Pneumococcal pneumonia causes over 100,000 child deaths in India annually. Uncertainty regarding the impact of introducing the pneumococcal conjugate vaccine and its high cost have been a concern, particularly after the proposed GAVI alliance support ends. We evaluate disease transmission and the vaccine’s disease and economic impact in an agent-based simulation model representative of the Indian population and healthcare system. Despite its high cost, introducing the vaccine averts a significant number of deaths and protects poor populations from financial risk.

Conference

ConferenceINFORMS Healthcare 2017
CountryNetherlands
CityRotterdam
Period26/07/1728/07/17
Internet address

Fingerprint

Immunization Programs
Conjugate Vaccines
Pneumococcal Vaccines
Systems Analysis
India
Vaccines
Economics
Pneumococcal Pneumonia
Costs and Cost Analysis
Population
Uncertainty
Delivery of Health Care

Keywords

  • india
  • national immunization programme

Cite this

@conference{0795a6dd16ca4c2aaf4263c412514164,
title = "Introducing the pneumococcal conjugate vaccine in India's National Immunization Programme: an economic-epidemiological analysis using agent-based modelling",
abstract = "Pneumococcal pneumonia causes over 100,000 child deaths in India annually. Uncertainty regarding the impact of introducing the pneumococcal conjugate vaccine and its high cost have been a concern, particularly after the proposed GAVI alliance support ends. We evaluate disease transmission and the vaccine’s disease and economic impact in an agent-based simulation model representative of the Indian population and healthcare system. Despite its high cost, introducing the vaccine averts a significant number of deaths and protects poor populations from financial risk.",
keywords = "india, national immunization programme",
author = "Itamar Megiddo",
year = "2017",
month = "7",
day = "28",
language = "English",
note = "INFORMS Healthcare 2017 ; Conference date: 26-07-2017 Through 28-07-2017",
url = "http://meetings2.informs.org/wordpress/healthcare2017/",

}

Introducing the pneumococcal conjugate vaccine in India's National Immunization Programme : an economic-epidemiological analysis using agent-based modelling. / Megiddo, Itamar.

2017. Abstract from INFORMS Healthcare 2017, Rotterdam, Netherlands.

Research output: Contribution to conferenceAbstract

TY - CONF

T1 - Introducing the pneumococcal conjugate vaccine in India's National Immunization Programme

T2 - an economic-epidemiological analysis using agent-based modelling

AU - Megiddo, Itamar

PY - 2017/7/28

Y1 - 2017/7/28

N2 - Pneumococcal pneumonia causes over 100,000 child deaths in India annually. Uncertainty regarding the impact of introducing the pneumococcal conjugate vaccine and its high cost have been a concern, particularly after the proposed GAVI alliance support ends. We evaluate disease transmission and the vaccine’s disease and economic impact in an agent-based simulation model representative of the Indian population and healthcare system. Despite its high cost, introducing the vaccine averts a significant number of deaths and protects poor populations from financial risk.

AB - Pneumococcal pneumonia causes over 100,000 child deaths in India annually. Uncertainty regarding the impact of introducing the pneumococcal conjugate vaccine and its high cost have been a concern, particularly after the proposed GAVI alliance support ends. We evaluate disease transmission and the vaccine’s disease and economic impact in an agent-based simulation model representative of the Indian population and healthcare system. Despite its high cost, introducing the vaccine averts a significant number of deaths and protects poor populations from financial risk.

KW - india

KW - national immunization programme

M3 - Abstract

ER -